Skip to main content
Clinical Trials/NCT03481647
NCT03481647
Recruiting
Not Applicable

Evaluation of an Oral Care Programme for Patients Undergoing Treatment for Head and Neck Cancer Regarding Mucositis, Oral Health, Epigenetic Modifications, Patient-related Factors, Quality of Life and Health Economy

Göteborg University2 sites in 1 country150 target enrollmentJanuary 8, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Head and Neck Cancer
Sponsor
Göteborg University
Enrollment
150
Locations
2
Primary Endpoint
Oral mucositis
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study will evaluate the effect of an intensified oral care programme on prevalence, severity and duration of mucositis in patients undergoing treatment for cancer in the head and neck region.

Patients in the control group get professional oral care once a week.

Detailed Description

This study will evaluate the effect of an oral care programme on prevalence, severity and duration of mucositis in patients undergoing treatment for cancer in the head and neck region. The oral care programme consists of professional oral care and swabbing of the mucosal membranes with a saline/bicarbonate solution once a week. The patients are instructed to rinse with a saline/bicarbonate solution 5 times per day. They are given an oral care diary to help them keep track of their daily oral hygiene measures and rinses. Repeated oral hygiene instructions are given if needed. Patients in the control group get professional oral care once a week.

Registry
clinicaltrials.gov
Start Date
January 8, 2018
End Date
December 31, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Göteborg University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled to receive full dose of curative RT including major salivary glands in the radiation field

Exclusion Criteria

  • Patients with recurrent cancer
  • Patients with severe cognitive impairment.

Outcomes

Primary Outcomes

Oral mucositis

Time Frame: Sixth week of RT (mucositis score at one time-point)

Reduced incidence of clinical mucositis assessed using Oral Mucositis Assessment Scale (9 areas in the mouth are examined and signs of ulceration are scored; 0=no lesion,1= lesion \<1cm2, 2=lesion 1-3 cm2, 3=lesion \> 3 cm2 as well as erythema, which is scored as follows: 0=no erythema, 1= mild erythema and 2=severe erythema. Total score for ulceration can vary from 0-27 and for erythema from 0-18. Mucositis is present at scores ≥ 1.)

Study Sites (2)

Loading locations...

Similar Trials